prof.dr. (Carin) CA Uyl - de Groot

Biography

Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.

Erasmus School of Health Policy & Management

Full professor | Health Technology Assessment (HTA)
Email
uyl@eshpm.eur.nl
Room
J8-35
Location
Burg. Oudlaan 50, Rotterdam

Erasmus School of Health Policy & Management

Researcher
Email
c.uyl-degroot@erasmusmc.nl

More information

Work

  • Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran

Cie Beoordeling Oncologische Middelen

Start date approval
July 2022
End date approval
July 2025
Place
UTRECHT

Gezondheidsraad

Start date approval
July 2022
End date approval
July 2025
Place
DEN HAAG

bestuurslid CPO, Erasmus Medisch Centrum

Start date approval
July 2022
End date approval
July 2025
Place
ONBEKEND

Master Thesis HEPL

Level
master
Year Level
master
Year
2023
Course Code
GW4555M

Cie Beoordeling Oncologische Middelen

Start date approval
July 2022
End date approval
July 2025
Place
UTRECHT

Gezondheidsraad

Start date approval
July 2022
End date approval
July 2025
Place
DEN HAAG

bestuurslid CPO, Erasmus Medisch Centrum

Start date approval
July 2022
End date approval
July 2025
Place
ONBEKEND

Master Thesis Eu-HEM

Level
master
Year Level
master
Year
2023
Course Code
GW4560M

Cie Beoordeling Oncologische Middelen

Start date approval
July 2022
End date approval
July 2025
Place
UTRECHT

Gezondheidsraad

Start date approval
July 2022
End date approval
July 2025
Place
DEN HAAG

bestuurslid CPO, Erasmus Medisch Centrum

Start date approval
July 2022
End date approval
July 2025
Place
ONBEKEND

Master Thesis HE

Year Level
master, master
Year
2023
Course Code
GW4592M

Cie Beoordeling Oncologische Middelen

Start date approval
July 2022
End date approval
July 2025
Place
UTRECHT

Gezondheidsraad

Start date approval
July 2022
End date approval
July 2025
Place
DEN HAAG

bestuurslid CPO, Erasmus Medisch Centrum

Start date approval
July 2022
End date approval
July 2025
Place
ONBEKEND

Module Knowledge

Level
bachelor 1
Year Level
bachelor 1
Year
2023
Course Code
GW114K

Cie Beoordeling Oncologische Middelen

Start date approval
July 2022
End date approval
July 2025
Place
UTRECHT

Gezondheidsraad

Start date approval
July 2022
End date approval
July 2025
Place
DEN HAAG

bestuurslid CPO, Erasmus Medisch Centrum

Start date approval
July 2022
End date approval
July 2025
Place
ONBEKEND

News regarding prof.dr. (Carin) CA Uyl - de Groot

Very inspiring start of ASCERTAIN Project in Rotterdam

In December 2022 the HORIZON funded project ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and Reimbursement

ASCERTAIN-project: improve affordability and sustainability innovative health technologies

The affordability of newly approved innovative health technologies is challenging in many health systems.
doctor in conversation with patient.

Corona science: Thousands of missed cancer diagnoses because patients don’t visit their GP

According to Uyl-de Groot, the problem is not only access to the GP, but it would also go wrong in secondary care, partly because of video calling as an…
(Carin) C. Uyl- de Groot ESHPM

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes